This 2000 systematic review by Fairbank and Pynsent examines the Oswestry Disability Index 20 years after its original 1980 publication. It catalogues all existing versions, collates validation data from over 114 studies, and establishes population benchmarks across spinal diagnostic categories. The primary goal is to standardize ODI use and support future trial design.
Every spine outcome paper you read in residency uses the ODI. Understanding what ODI scores mean across diagnostic categories, and what constitutes a real change, is essential for evaluating surgical literature critically.
When a spinal fusion trial reports improvement, two thresholds matter: a 4-point group mean difference is the minimum clinically significant difference between treatment arms, while a 15-point individual change is the FDA standard for calling a single patient improved.
When choosing between ODI and Roland-Morris for a patient population, use the ODI for more severely disabled surgical patients and Roland-Morris for primary care or mildly affected patients — the ODI's detection efficiency is better matched to the higher end of the disability spectrum.
Version consistency is not a minor administrative detail. The AAOS/MODEMS version omits three sections and uses a 1-6 scoring scale instead of 0-5, making scores from that version non-comparable to Versions 1.0 and 2.0. Always report which version was used when citing ODI data.
This 2000 systematic review by Fairbank and Pynsent examines the Oswestry Disability Index 20 years after its original 1980 publication. It catalogues all existing versions, collates validation data from over 114 studies, and establishes population benchmarks across spinal diagnostic categories. The primary goal is to standardize ODI use and support future trial design.
Every spine outcome paper you read in residency uses the ODI. Understanding what ODI scores mean across diagnostic categories, and what constitutes a real change, is essential for evaluating surgical literature critically.
When a spinal fusion trial reports improvement, two thresholds matter: a 4-point group mean difference is the minimum clinically significant difference between treatment arms, while a 15-point individual change is the FDA standard for calling a single patient improved.
When choosing between ODI and Roland-Morris for a patient population, use the ODI for more severely disabled surgical patients and Roland-Morris for primary care or mildly affected patients — the ODI's detection efficiency is better matched to the higher end of the disability spectrum.
Version consistency is not a minor administrative detail. The AAOS/MODEMS version omits three sections and uses a 1-6 scoring scale instead of 0-5, making scores from that version non-comparable to Versions 1.0 and 2.0. Always report which version was used when citing ODI data.